This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "RIMBAA 201003 Minutes"

From HL7Wiki
Jump to navigation Jump to search
Line 12: Line 12:
 
|R||Adri Burggraaff||Slotervaartziekenhuis, NL||adri.burggraaff@slz.nl
 
|R||Adri Burggraaff||Slotervaartziekenhuis, NL||adri.burggraaff@slz.nl
 
|-
 
|-
|R||Andrea Ceiner||ItalTBS, IT||andrea.ceiner@italtbs.com
+
|X||Andrea Ceiner||ItalTBS, IT||andrea.ceiner@italtbs.com
 
|-
 
|-
 
|E||Andy Harris||National Institute of Health Research (NIHR), UK||&nbsp;
 
|E||Andy Harris||National Institute of Health Research (NIHR), UK||&nbsp;
Line 20: Line 20:
 
|?||Arvid Nicolaas||Philips, NL||&nbsp;
 
|?||Arvid Nicolaas||Philips, NL||&nbsp;
 
|-
 
|-
|R||Bas van Poppel||iSoft, NL||bas.vpoppel@isofthealth.com
+
|X||Bas van Poppel||iSoft, NL||bas.vpoppel@isofthealth.com
 
|-
 
|-
 
|?||Bertil Reppen||Apertura, NO||&nbsp;
 
|?||Bertil Reppen||Apertura, NO||&nbsp;
 
|-
 
|-
|R||Davide Magni||ItalTBS, IT||davide.magni@italtbs.com
+
|X||Davide Magni||ItalTBS, IT||davide.magni@italtbs.com
 
|-
 
|-
|R||Ewout Kramer||Furore, NL||&nbsp;
+
|X||Ewout Kramer||Furore, NL||&nbsp;
 
|-
 
|-
 
|R||Freek Geerdink||Vrumun, NL||freek.geerdink@vrumun.nl
 
|R||Freek Geerdink||Vrumun, NL||freek.geerdink@vrumun.nl
 
|-
 
|-
|R||Hans Jonkers||Philips, NL||hans.jonkers@philips.com
+
|X||Hans Jonkers||Philips, NL||hans.jonkers@philips.com
 
|-
 
|-
 
|R||Henk Enting||MGRID, NL||&nbsp;
 
|R||Henk Enting||MGRID, NL||&nbsp;
Line 36: Line 36:
 
|?||Kjetil Sanders||CSAM Health, NO||Kjetil.Sanders@csamhealth.com
 
|?||Kjetil Sanders||CSAM Health, NO||Kjetil.Sanders@csamhealth.com
 
|-
 
|-
|R||Michael van der Zel||UMCG and Results4care, NL||m.van.der.zel@ict.umcg.nl
+
|X||Michael van der Zel||UMCG and Results4care, NL||m.van.der.zel@ict.umcg.nl
 
|-
 
|-
 
|R||Rene Spronk||Ringholm, NL||rene.spronk@ringholm.com
 
|R||Rene Spronk||Ringholm, NL||rene.spronk@ringholm.com
Line 42: Line 42:
 
|?||Roelof Middeljans||UMCG, NL||&nbsp;
 
|?||Roelof Middeljans||UMCG, NL||&nbsp;
 
|-
 
|-
|R||Tessa van Steijn||Nictiz, NL||stijn@nictiz.nl
+
|X||Tessa van Steijn||Nictiz, NL||stijn@nictiz.nl
 
|-
 
|-
 
|?||Tom de Jong||NovaPro, NL||&nbsp;
 
|?||Tom de Jong||NovaPro, NL||&nbsp;
Line 48: Line 48:
 
|?||Tommy Kristiansen||CSAM Health, NO||tommy.kristiansen@csamhealth.com
 
|?||Tommy Kristiansen||CSAM Health, NO||tommy.kristiansen@csamhealth.com
 
|-
 
|-
|R||Willem Dijkstra||MGRID, NL||&nbsp;
+
|X||Willem Dijkstra||MGRID, NL||&nbsp;
 
|-
 
|-
|R||Yeb Havinga||MGRID, NL||y.t.havinga@mgrid.net
+
|X||Yeb Havinga||MGRID, NL||y.t.havinga@mgrid.net
 
|}
 
|}
 
*'''Co-chairs:''' Rene Spronk (co-chair of the RIMBAA WG, co-chair of the Dutch RIMBAA SIG) & Michael van der Zel (co-chair of the Dutch RIMBAA SIG)
 
*'''Co-chairs:''' Rene Spronk (co-chair of the RIMBAA WG, co-chair of the Dutch RIMBAA SIG) & Michael van der Zel (co-chair of the Dutch RIMBAA SIG)

Revision as of 10:39, 11 March 2010

RIMBAA WG Minutes, 2010-02-11

On March 11 an international RIMBAA meeting was held in Amsterdam. The meeting was co-hosted by HL7 the Netherlands and HL7 Inc..

  • Attendees:
At Name Affiliation Email Address
R Adri Burggraaff Slotervaartziekenhuis, NL adri.burggraaff@slz.nl
X Andrea Ceiner ItalTBS, IT andrea.ceiner@italtbs.com
E Andy Harris National Institute of Health Research (NIHR), UK  
? Arild Hollas CSAM Health, NO arild.hollas@csamhealth.com
? Arvid Nicolaas Philips, NL  
X Bas van Poppel iSoft, NL bas.vpoppel@isofthealth.com
? Bertil Reppen Apertura, NO  
X Davide Magni ItalTBS, IT davide.magni@italtbs.com
X Ewout Kramer Furore, NL  
R Freek Geerdink Vrumun, NL freek.geerdink@vrumun.nl
X Hans Jonkers Philips, NL hans.jonkers@philips.com
R Henk Enting MGRID, NL  
? Kjetil Sanders CSAM Health, NO Kjetil.Sanders@csamhealth.com
X Michael van der Zel UMCG and Results4care, NL m.van.der.zel@ict.umcg.nl
R Rene Spronk Ringholm, NL rene.spronk@ringholm.com
? Roelof Middeljans UMCG, NL  
X Tessa van Steijn Nictiz, NL stijn@nictiz.nl
? Tom de Jong NovaPro, NL  
? Tommy Kristiansen CSAM Health, NO tommy.kristiansen@csamhealth.com
X Willem Dijkstra MGRID, NL  
X Yeb Havinga MGRID, NL y.t.havinga@mgrid.net
  • Co-chairs: Rene Spronk (co-chair of the RIMBAA WG, co-chair of the Dutch RIMBAA SIG) & Michael van der Zel (co-chair of the Dutch RIMBAA SIG)
  • Scribe: Rene Spronk

Agenda:

  1. Administrative
  2. Highlights from prior RIMBAA meetings on other continents (Rene, max. 30 minutes)
  3. RIMBAA: SAEAF vs RIMBAA (Michael van der Zel)
    • a presentation of the way in which the RIMBAA fits within the HL7 Enterprise Architecture Framework.
  4. Update of new developments/changes in core v3 modeling (Ewout Kramer).
    • Context Conduction. The way in which context conduction will be supported has been radically changed during the recent meeting in Phoenix.
    • RIM ITS overview. The RIM ITS provides an alternative way of expressing RIM-based-object-trees in XML. The encoding is based on the RS-cell of the technology matrix and is well suited for the exchange of data between RIM based applications.
  5. MDD - Model Driven Development
    • (Rene Spronk) Introductory presentation: http://www.ringholm.de/persist/20100304_HL7UK_MDD.ppt
    • (Davide Magni) How does PHI apply MDD? PHI Technology is the most advanced MDD toolsuite (based on RIMB based information models) we know of. ITAL TBS (the developers of PHI) have gained ample experience in applying generic MDD principles in healthcare.
  6. MIF based code generation
    • (Hans Jonkers) Introduction to MIF
      • Hans will present some of the basic characteristics of MIF. He has only used those parts of the MIF he needed to build his application (see agenda item 6 of these RIMBAA minutes for a presentation of the application). He has created an object model based on the MIF schema.
    • (Rene Spronk) Overview and discussion of this draft paper: MIF based code generation.
      • By now the RIMBAA WG has received feedback from a number of MIF based code generation approaches, which allow us to create an initial description of some of the best practices.
  7. Various product/concept presentations (te be added)
  8. Discussion of RIMBAA Issues